Skip to main content
main-content

Zeitschrift

Breast Cancer Research and Treatment

Breast Cancer Research and Treatment 1/2016

Ausgabe 1/2016

Inhaltsverzeichnis ( 20 Artikel )

20.04.2016 | Review | Ausgabe 1/2016

Effect of polyphenols on glucose and lactate transport by breast cancer cells

F. Martel, M. Guedes, E. Keating

23.04.2016 | Review | Ausgabe 1/2016

Potential of breastmilk analysis to inform early events in breast carcinogenesis: rationale and considerations

Jeanne Murphy, Mark E. Sherman, Eva P. Browne, Ana I. Caballero, Elizabeth C. Punska, Ruth M. Pfeiffer, Hannah P. Yang, Maxwell Lee, Howard Yang, Gretchen L. Gierach, Kathleen F. Arcaro

15.04.2016 | Preclinical study | Ausgabe 1/2016

The CYP17A1 inhibitor abiraterone exhibits estrogen receptor agonist activity in breast cancer

Cameron P. Capper, José M. Larios, Matthew J. Sikora, Michael D. Johnson, James M. Rae

18.04.2016 | Preclinical study | Ausgabe 1/2016

Apparent diffusion coefficient of breast cancer and normal fibroglandular tissue in diffusion-weighted imaging: the effects of menstrual cycle and menopausal status

Jin You Kim, Hie Bum Suh, Hyun Jung Kang, Jong Ki Shin, Ki Seok Choo, Kyung Jin Nam, Seok Won Lee, Young Lae Jung, Young Tae Bae

21.04.2016 | Preclinical study | Ausgabe 1/2016

Withaferin A inhibits in vivo growth of breast cancer cells accelerated by Notch2 knockdown

Su-Hyeong Kim, Eun-Ryeong Hahm, Julie A. Arlotti, Suman K. Samanta, Michelle B. Moura, Stephen H. Thorne, Yongli Shuai, Carolyn J. Anderson, Alexander G. White, Anna Lokshin, Joomin Lee, Shivendra V. Singh

25.04.2016 | Preclinical Study | Ausgabe 1/2016

Protective effect of naturally occurring anti-HER2 autoantibodies on breast cancer

Yukiko Tabuchi, Masafumi Shimoda, Naofumi Kagara, Yasuto Naoi, Tomonori Tanei, Atsushi Shimomura, Kenzo Shimazu, Seung Jin Kim, Shinzaburo Noguchi

26.04.2016 | Preclinical study | Ausgabe 1/2016 Open Access

Nottingham prognostic index plus (NPI+) predicts risk of distant metastases in primary breast cancer

Andrew R. Green, D. Soria, D. G. Powe, C. C. Nolan, M. Aleskandarany, M. A. Szász, A. M. Tőkés, G. R. Ball, J. M. Garibaldi, E. A. Rakha, J. Kulka, I. O. Ellis

27.04.2016 | Preclinical Study | Ausgabe 1/2016 Open Access

Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer

A. Thakkar, B. Wang, M. Picon-Ruiz, P. Buchwald, Tan A. Ince

23.04.2016 | Clinical trial | Ausgabe 1/2016 Open Access

Prognostic impact of breast cancer subtypes in elderly patients

E. S. Bergen, C. Tichy, A. S. Berghoff, M. Rudas, P. Dubsky, Z. Bago-Horvath, R. M. Mader, R. Exner, M. Gnant, C. C. Zielinski, G. G. Steger, M. Preusser, R. Bartsch

26.04.2016 | Clinical Trial | Ausgabe 1/2016

Relapse-free survival of statistically standardized continuous RT-PCR estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2): NCIC CTG MA.14

Judith-Anne W. Chapman, Dennis C. Sgroi, Paul E. Goss, Elizabeth Zarella, Shemeica Binns, Yi Zhang, Catherine A. Schnabel, Mark G. Erlander, Kathleen I. Pritchard, Lei Han, Tanja Badovinac-Crnjevic, Lois E. Shepherd, Michael N. Pollak

26.04.2016 | Clinical trial | Ausgabe 1/2016

Canadian Cancer Trials Group IND197: a phase II study of foretinib in patients with estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2-negative recurrent or metastatic breast cancer

Daniel Rayson, Sasha Lupichuk, Kylea Potvin, Susan Dent, Tamara Shenkier, Sukhbinder Dhesy-Thind, Susan L. Ellard, Catherine Prady, Muhammad Salim, Patricia Farmer, Ghasson Allo, Ming-Sound Tsao, Alison Allan, Olga Ludkovski, Maria Bonomi, Dongsheng Tu, Linda Hagerman, Rachel Goodwin, Elizabeth Eisenhauer, Penelope Bradbury

15.04.2016 | Epidemiology | Ausgabe 1/2016

Genes associated with histopathologic features of triple negative breast tumors predict molecular subtypes

Kristen S. Purrington, Daniel W. Visscher, Chen Wang, Drakoulis Yannoukakos, Ute Hamann, Heli Nevanlinna, Angela Cox, Graham G. Giles, Jeanette E. Eckel-Passow, Sotiris Lakis, Vassiliki Kotoula, George Fountzilas, Maria Kabisch, Thomas Rüdiger, Päivi Heikkilä, Carl Blomqvist, Simon S. Cross, Melissa C. Southey, Janet E. Olson, Judy Gilbert, Sandra Deming-Halverson, Veli-Matti Kosma, Christine Clarke, Rodney Scott, J. Louise Jones, Wei Zheng, Arto Mannermaa, Diana M. Eccles, Celine M. Vachon, Fergus J. Couch, Jane Carpenter for ABCTC Investigators

16.04.2016 | Epidemiology | Ausgabe 1/2016

Psychosocial factors related to non-persistence with adjuvant endocrine therapy among women with breast cancer: the Breast Cancer Quality of Care Study (BQUAL)

Dawn L. Hershman, Lawrence H. Kushi, Grace Clarke Hillyer, Ellie Coromilas, Donna Buono, Lois Lamerato, Dana H. Bovbjerg, Jeanne S. Mandelblatt, Wei-Yann Tsai, Xiaobo Zhong, Judith S. Jacobson, Jason D. Wright, Alfred I. Neugut

23.04.2016 | Epidemiology | Ausgabe 1/2016 Open Access

Delay in initiation of adjuvant trastuzumab therapy leads to decreased overall survival and relapse-free survival in patients with HER2-positive non-metastatic breast cancer

Christopher M. Gallagher, Kenneth More, Tripthi Kamath, Anthony Masaquel, Annie Guerin, Raluca Ionescu-Ittu, Marjolaine Gauthier-Loiselle, Roy Nitulescu, Nicholas Sicignano, Elizabeth Butts, Eric Q. Wu, Brian Barnett

25.04.2016 | Epidemiology | Ausgabe 1/2016

Neo-adjuvant doxorubicin and cyclophosphamide followed by paclitaxel in triple-negative breast cancer among BRCA1 mutation carriers and non-carriers

Shani Paluch-Shimon, Eitan Friedman, Raanan Berger, Moshe Papa, Maya Dadiani, Neil Friedman, Moshe Shabtai, Dov Zippel, Mordechai Gutman, Talia Golan, Ady Yosepovich, Raphael Catane, Tami Modiano, Bella Kaufman

26.04.2016 | Epidemiology | Ausgabe 1/2016

Ethnic differences in the relationships between diabetes, early age adiposity and mortality among breast cancer survivors: the Breast Cancer Health Disparities Study

Avonne E. Connor, Kala Visvanathan, Kathy B. Baumgartner, Richard N. Baumgartner, Stephanie D. Boone, Lisa M. Hines, Roger K. Wolff, Esther M. John, Martha L. Slattery

27.04.2016 | Epidemiology | Ausgabe 1/2016

Association of adiposity, dysmetabolisms, and inflammation with aggressive breast cancer subtypes: a cross-sectional study

Roberto Agresti, Elisabetta Meneghini, Paolo Baili, Pamela Minicozzi, Alberto Turco, Ilaria Cavallo, Francesco Funaro, Hade Amash, Franco Berrino, Elda Tagliabue, Milena Sant

22.04.2016 | Brief Report | Ausgabe 1/2016

Bi-weekly very-high-dose lapatinib: an easy-to-use active option in HER-2-positive breast cancer patients with meningeal carcinomatosis

P. Lavaud, B. Rousseau, Z. Ajgal, J. Arrondeau, O. Huillard, J. Alexandre, A. Hulin, F. Goldwasser

27.04.2016 | Brief Report | Ausgabe 1/2016

Racial differences in receipt of adjuvant hormonal therapy among Medicaid enrollees in South Carolina diagnosed with breast cancer

Tisha M. Felder, D. Phuong Do, Z. Kevin Lu, Lincy S. Lal, Sue P. Heiney, Charles L. Bennett

26.04.2016 | Letter to the Editor | Ausgabe 1/2016

Compliance with hormonal therapy

Henry J. Carson, Chirantan Ghosh

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise